Peter Curreri in Merchantville, New Jersey

Home New Jersey Merchantville

Peter Curreri has Pulmonary Disease as his primary medical specialty. Their primary office is: 124 Lexington Ave in Merchantville, New Jersey.

They're a part of the: Peter A. Curreri, D.o., L.l.c. medical group which has around 3 members. You can call their office at 856-663-1121 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Philadelphia College Of Osteopathic Medicine and graduated in 1997 (around 27 years of experience). They are listed as doing telehealth appointments.

Peter A Curreri Office Phone and Directions

Peter Curreri
Peter A. Curreri, D.o., L.l.c.
124 Lexington Ave
Merchantville, New Jersey 08109
856-663-1121

Patient Ratings
Please rate your experience with Peter Curreri below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 856-663-1121

Enter a starting address:

Healthcare Info for Peter Curreri

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: Philadelphia College Of Osteopathic Medicine
Graduation Year: 1997
The Primary Medical Specialty for Peter Curreri is listed as: Pulmonary Disease
Approximate Years of Experience: 27
PAC (PECOS ID)#: 8527159359
NPI #: 1053397356
NPI Created On: 12/19/2005
NPI Last Updated Listed as: 06/09/2012
Primary Taxonomy Code: 207RP1001X
License Number:
25MB06800600
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

AmeriHealth New Jersey
Blue Cross Blue Shield
Humana
Oscar Garden State Insurance Corporation
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

Vaccine for influenza for administration into muscle, 0.5 ml dosage
Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Hospital observation care on day of discharge
Hospital observation care, typically 70 minutes
Initial hospital inpatient care, typically 50 minutes per day
Initial hospital inpatient care, typically 70 minutes per day
Subsequent observation care, typically 35 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day
Subsequent hospital inpatient care, typically 35 minutes per day
Hospital discharge day management, more than 30 minutes
Critical care delivery critically ill or injured patient, first 30-74 minutes
Initial nursing facility visit, typically 45 minutes per day
Subsequent nursing facility visit, typically 10 minutes per day
Subsequent nursing facility visit, typically 15 minutes per day
Subsequent nursing facility visit, typically 25 minutes per day
Nursing facility discharge management, more than 30 minutes
Administration of influenza virus vaccine
Physician certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial implem

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 818674561

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Diabetes

Name of Drug #1: TRULICITY

Open Associated Drug #1: 0002-1433-80

Drug or Biological: Drug

Product Category #2: Diabetes

Name Of Drug #2:: JARDIANCE

Associated Drug #2: 0597-0152-37

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 818687923

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Diabetes

Name of Drug #1: BASAGLAR

Open Associated Drug #1: 0002-7715-59

Drug or Biological: Drug

Product Category #2: Diabetes

Name Of Drug #2:: TRULICITY

Associated Drug #2: 0002-1433-80

Drug or Biological #3:: Drug

Product Category #3: Diabetes

Name of Drug: JARDIANCE

Name Of Drug #3: 0597-0152-37

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 818715511

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Diabetes

Name of Drug #1: TRULICITY

Open Associated Drug #1: 0002-1433-80

Drug or Biological: Drug

Product Category #2: Diabetes

Name Of Drug #2:: JARDIANCE

Associated Drug #2: 0597-0152-37

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 818715679

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Diabetes

Name of Drug #1: TRULICITY

Open Associated Drug #1: 0002-1433-80

Drug or Biological: Drug

Product Category #2: Diabetes

Name Of Drug #2:: JARDIANCE

Associated Drug #2: 0597-0152-37

Payments Total: $11

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801859815

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801861425

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Drug or Biological: Drug

Product Category #2: RESPIRATORY

Name Of Drug #2:: ANORO ELLIPTA

Associated Drug #2: 0173-0869-06

Payments Total: $10

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801863329

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: ANORO ELLIPTA

Open Associated Drug #1: 0173-0869-06

Payments Total: $6

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801976971

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: ANORO ELLIPTA

Open Associated Drug #1: 0173-0869-06

Payments Total: $11

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802448227

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: NUCALA

Open Associated Drug #1: 0173-0881-01

Payments Total: $10

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802656615

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: NUCALA

Open Associated Drug #1: 0173-0881-01

Pulmonary Disease Professionals in Merchantville

1.
Joseph Curreri

124 Lexington Ave
Merchantville, NJ
Joseph P. Curreri, D.o., Llc

Providers in Peter A. Curreri, D.o., L.l.c.

1.Peter Curreri

124 Lexington Ave
Merchantville Nj 08109-2031
Peter A. Curreri, D.o., L.l.c.
Pulmonary Disease

2.Brian Shannon

124 Lexington Ave
Merchantville Nj 08109-2031
Peter A. Curreri, D.o., L.l.c.
Nurse Practitioner

3.Jennifer Sittineri

124 Lexington Ave
Merchantville Nj 08109-2031
Peter A. Curreri, D.o., L.l.c.
Nurse Practitioner

View all 3 members of Peter A. Curreri, D.o., L.l.c. medical group